Ligand validation:6RF3

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6RF3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
6RF3_OLC_C_301	56%	47%	0.137	0.941	0.97	0.97	1	1	0	84%	1
6RF3_OLC_E_305	52%	48%	0.152	0.92	0.95	0.97	1	2	3	96%	1
6RF3_OLC_C_305	45%	48%	0.16	0.908	0.99	0.91	1	2	2	92%	1
6RF3_OLC_A_303	45%	49%	0.157	0.912	0.99	0.89	1	2	0	88%	1
6RF3_OLC_E_309	42%	50%	0.186	0.908	0.93	0.89	1	2	1	100%	1
6RF3_OLC_A_321	38%	50%	0.197	0.902	0.96	0.87	1	1	0	100%	1
6RF3_OLC_B_306	38%	46%	0.174	0.914	1.07	0.91	1	1	1	80%	1
6RF3_OLC_B_301	37%	49%	0.177	0.879	0.96	0.91	1	1	4	100%	1
6RF3_OLC_A_309	36%	37%	0.141	0.906	1.24	1.15	1	2	0	60%	1
6RF3_OLC_E_301	36%	50%	0.203	0.899	0.95	0.88	1	1	2	100%	1
6RF3_OLC_D_307	35%	38%	0.137	0.908	1.25	1.08	1	2	0	56%	1
6RF3_OLC_E_307	33%	45%	0.168	0.886	1.06	0.96	1	1	0	80%	1
6RF3_OLC_C_311	32%	41%	0.147	0.89	1.19	0.99	1	2	1	64%	1
6RF3_OLC_B_308	31%	44%	0.161	0.87	1.08	0.97	1	2	0	80%	1
6RF3_OLC_E_314	29%	50%	0.193	0.854	0.96	0.87	1	1	0	100%	1
6RF3_OLC_B_309	28%	44%	0.174	0.858	1.05	1.01	1	1	0	84%	1
6RF3_OLC_A_305	27%	34%	0.139	0.878	1.32	1.2	1	2	0	52%	1
6RF3_OLC_C_312	27%	40%	0.174	0.893	1.22	1.03	1	1	0	64%	1
6RF3_OLC_D_304	26%	41%	0.174	0.872	1.13	1.08	1	1	1	72%	1
6RF3_OLC_D_301	26%	42%	0.196	0.892	1.13	1.02	1	1	0	72%	1
6RF3_OLC_E_304	25%	40%	0.163	0.869	1.18	1.06	1	2	4	64%	1
6RF3_OLC_B_313	24%	42%	0.2	0.895	1.17	0.97	1	1	1	68%	1
6RF3_OLC_C_308	23%	46%	0.19	0.84	1.02	0.96	1	2	0	88%	1
6RF3_OLC_D_305	23%	50%	0.196	0.839	1	0.83	1	1	0	92%	1
6RF3_OLC_B_311	23%	50%	0.191	0.816	0.98	0.87	1	2	0	100%	1
6RF3_OLC_A_311	22%	39%	0.203	0.895	1.25	1.03	1	1	2	64%	1
6RF3_OLC_D_308	22%	42%	0.18	0.877	1.24	0.93	1	1	0	60%	1
6RF3_OLC_C_310	22%	51%	0.206	0.828	0.96	0.84	1	1	0	100%	1
6RF3_OLC_D_309	21%	52%	0.246	0.865	0.96	0.79	1	1	0	100%	1
6RF3_OLC_C_313	21%	37%	0.211	0.893	1.26	1.1	1	1	0	64%	1
6RF3_OLC_B_304	21%	49%	0.203	0.817	0.98	0.88	1	1	1	100%	1
6RF3_OLC_A_302	20%	50%	0.24	0.85	0.97	0.84	1	1	1	100%	1
6RF3_OLC_E_306	19%	49%	0.208	0.82	1	0.86	1	2	2	96%	1
6RF3_OLC_A_304	19%	50%	0.2	0.803	0.98	0.85	1	1	1	100%	1
6RF3_OLC_B_310	19%	40%	0.167	0.831	1.22	1.03	1	1	0	64%	1
6RF3_OLC_E_310	19%	41%	0.197	0.87	1.22	0.96	1	1	1	60%	1
6RF3_OLC_E_312	19%	50%	0.24	0.842	0.98	0.86	1	1	4	100%	1
6RF3_OLC_A_308	18%	49%	0.197	0.791	0.97	0.89	1	1	1	100%	1
6RF3_OLC_B_312	18%	44%	0.17	0.828	1.13	0.95	1	2	0	64%	1
6RF3_OLC_C_307	18%	49%	0.193	0.785	0.97	0.91	1	1	0	100%	1
6RF3_OLC_C_304	17%	46%	0.247	0.87	1.07	0.91	1	1	3	84%	1
6RF3_OLC_C_303	15%	38%	0.19	0.84	1.27	1.06	1	1	0	56%	1
6RF3_OLC_B_315	14%	40%	0.243	0.871	1.27	0.98	1	1	1	64%	1
6RF3_OLC_C_306	12%	49%	0.223	0.768	0.97	0.91	1	1	0	100%	1
6RF3_OLC_B_307	11%	50%	0.237	0.773	0.98	0.87	1	1	0	96%	1
6RF3_OLC_D_303	11%	48%	0.238	0.762	0.97	0.93	1	1	0	100%	1
6RF3_OLC_A_301	10%	40%	0.178	0.768	1.22	1.03	1	1	1	60%	1
6RF3_OLC_E_308	10%	38%	0.191	0.775	1.25	1.08	1	1	0	60%	1
6RF3_OLC_A_310	9%	43%	0.25	0.823	1.18	0.95	1	1	1	64%	1
6RF3_OLC_D_306	9%	47%	0.221	0.724	1.01	0.92	1	1	0	100%	1
6RF3_OLC_A_306	9%	40%	0.19	0.763	1.23	1.02	1	1	1	60%	1
6RF3_OLC_D_302	8%	35%	0.209	0.786	1.34	1.13	1	1	1	52%	1
6RF3_OLC_B_305	8%	40%	0.231	0.791	1.24	0.99	1	1	0	60%	1
6RF3_OLC_B_303	7%	37%	0.21	0.759	1.26	1.11	1	1	0	56%	1
6RF3_OLC_E_313	7%	43%	0.231	0.727	1.1	1.01	1	1	0	80%	1
6RF3_OLC_E_303	6%	37%	0.212	0.75	1.3	1.08	1	1	3	56%	1
6RF3_OLC_B_314	6%	39%	0.23	0.745	1.27	1.01	1	1	0	60%	1
6RF3_OLC_E_311	4%	30%	0.201	0.707	1.48	1.22	1	2	0	44%	1
6RF3_OLC_A_307	4%	34%	0.226	0.696	1.21	1.3	1	2	1	64%	1
6RF3_OLC_C_309	4%	38%	0.243	0.699	1.24	1.11	1	1	1	64%	1
9I6I_OLC_B_312	73%	44%	0.098	0.964	0.87	1.2	-	1	0	80%	1
6YC0_OLC_C_301	72%	47%	0.108	0.964	1.01	0.94	1	1	1	84%	1
9I6H_OLC_B_311	71%	44%	0.097	0.958	0.87	1.19	-	1	3	80%	1
6YC3_OLC_A_316	68%	48%	0.091	0.946	1.09	0.82	1	-	1	76%	1
6YC1_OLC_A_317	67%	49%	0.088	0.94	1.11	0.78	1	-	3	76%	1
5ZIH_OLC_B_401	99%	50%	0.041	0.988	0.83	0.98	2	1	1	100%	1
5OGK_OLC_A_402	97%	57%	0.058	0.986	0.77	0.72	-	-	1	100%	1
7O8K_OLC_A_303	97%	54%	0.049	0.975	0.73	0.92	1	1	0	100%	1
9F9J_OLC_A_307	97%	39%	0.044	0.966	1.07	1.19	1	2	0	100%	1
7B1K_OLC_A_308	95%	51%	0.06	0.973	0.81	0.98	2	1	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

Prepare Data

Validate Data

Deposit Data

Help and Resources

.id_divider{ color: #ccc; padding: 0 10px 0 10px; } .extended_id_info{ color: #ccc; font-size: 18px; position: relative; top: -10px; left: 4px; } 6RF3 | pdb_00006rf3

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6RF3 designated by the RCSB

6RF3 | pdb_00006rf3